Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Mar 14, 2008; 14(10): 1617-1621
Published online Mar 14, 2008. doi: 10.3748/wjg.14.1617
Table 1 Clinical and serological data from patients studied (mean ± SD)
GroupnAge (yr)HBsAgHBeAgAnti-HBcHBV-DNA (IU/mL)ALT1 (nkat/L)
Patients2525.7 (18-42)+++> 2.0E + 042645.09 ± 1799.87
Volunteers1026.2 (24-32)---NT311.28 ± 83.40
Table 2 Expression of costimulatory molecules on DCs from different groups of patients (mean ± SD)
nCD1aCD80CD83HLA-DR
Healthy control DC1039.41 ± 3.1238.52 ± 3.1840.76 ± 3.1559.62 ± 4.73
CHB control DC2526.85 ± 2.80b25.75 ± 2.51b23.21 ± 3.10b32.20 ± 3.04b
ETV-treated DC2529.07 ± 3.20a28.00 ± 2.76a25.66 ± 3.19a41.96 ± 3.81a